Navigation Links
Oklahoma State University researchers make breakthrough against poxviruses
Date:1/23/2009

Stillwater, Okla. Smallpox has a nasty history throughout the world. Caused by poxviruses, smallpox is one of the few disease-causing agents against which the human body's immune system is ineffective in its defense.

A major breakthrough by Junpeng Deng, a structural biologist in the Division of Agricultural Sciences and Natural Resources (DASNR) at Oklahoma State University, and his first-year Ph.D. student, Brian Krumm, may be the first step towards a pharmaceutical medication for smallpox and the emerging human monkeypox.

The human immune system is rendered helpless against poxviruses partly because the viruses block a human immune molecule, interleukin-18 (IL-18), from sending out a signal to the immune system. The body acts as if everything is fine and the deadly disease takes over.

Deng and Krumm joined an ongoing project midway through 2007 and Krumm found what he was looking for in December 2008. They solved a three-dimensional crystal structure of a poxvirus protein in the act of disarming the IL-18.

"We capped a lot of others' research. This is additional information provided," said Krumm, who is credited as the major contributor to the research. "We also show many things through the structure that can't be revealed through traditional molecular biology and immunology."

The study is published in the Dec. 22 early online edition of the Proceedings of the National Academy of Sciences of the United States of America.

"We know now how the proteins communicate with each other," Deng said. "In the future, we can design a drug to stop the poxvirus from blocking the IL-18 protein."

As there is currently no medication for poxvirus-caused diseases, this research could aid national and international security efforts against potential poxvirus use as bioterrorism.

Deng called the finding an example of "killing two birds with one stone."

"At this time we only have very limited medication to treat autoimmune diseases," he said.

For example, rheumatoid arthritis is one of the most prevalent autoimmune diseases in which IL-18 is too active, leading to the body attacking its own cells. Deng said seeing how IL-18 interacts with the poxviruses will help with the development of effective inhibitors against overreaction.

"There are still a lot of questions to be answered. This is just the beginning," Deng said. "This opened up a new area to explore: How we design medication for autoimmune diseases. We want to provide more and more structural insights."

Deng and Krumm will continue to do research in the lab created two years ago in November 2006, when Deng joined OSU with funding provided by a start-up fund from DASNR.

"Junpeng is a relatively new assistant professor at OSU and has already demonstrated some excellent work," said Gary Thompson, head of the department of biochemistry and molecular biology. "I'm really impressed with not only Junpeng, but also the quality of work from his Ph.D. students."

Deng and Krumm did their research in the lab at OSU, but recognize the help they had from other researchers.

"Credit also goes to Yan Xiang and Xiangzhi Meng, our collaborators at the University of Texas Health Science Center at San Antonio," Deng said of the multi-institutional effort. "I believe our excellent collaboration will bring more success in the future."


'/>"/>

Contact: Sean Hubbard
sean.hubbard@okstate.edu
405-744-4490
Oklahoma State University
Source:Eurekalert

Related medicine news :

1. Inside out Applesauce Fueling Oklahomas Title Quest
2. Blue Cross and Blue Shield of Oklahoma Announces Autism Benefits
3. Oklahoma Parents Can Prevent Holiday Tragedies with Safe Toys and Celebrations
4. Second Annual Eye Ball Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology
5. The Most Ordinary Things Can Cause the Most Extraordinary Eye Injuries, Says the Oklahoma Academy of Ophthalmology
6. Grubb & Ellis Healthcare REIT Acquires Oklahoma City Medical Portfolio
7. DNC: Bush-McCain Alert - President Touts Bush-McCain Health Care Agenda in Oklahoma
8. Oklahoma Students Win Be Smart-Dont Start! Contest
9. Blue Cross and Blue Shield of Oklahoma Launches an Integrated Medical-Dental Health Program
10. LCA-Vision Announces the Opening of its 75th LasikPlus(R) Vision Center in Tulsa, Oklahoma
11. State Leaders Recognize Oklahomas Improvement in Immunization Rankings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Intellitec Solutions announced the publication of a case study ... solution that integrates to their PointClickCare EHR software package. With the guidance of ... now has the capability to achieve its goal for a comprehensive EHR solution, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Healthcare companies ... But they will rapidly reject an outdated healthcare executive resume. , “If you’re a ... at your executive resume and wondering if it’s as ready as you are for ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, ... sponsorship at MobileIron Live! 2017 in Santa Clara, California. Each year, ... educational approach to helping organizations maximize the benefits of mobility in their operations ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to ... to present at the upcoming Aesthetic Meeting. Held in San Diego, at the San ... and Canales will lend their expertise to the Premier Global Hot Topics session, speaking ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology: